Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New digital tests aim to spot dementia sooner in seniors

NCT ID NCT06224205

Diagnosis Sponsor: Indiana University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study tests whether simple digital questionnaires can help primary care doctors identify new cases of Alzheimer's and related dementias during annual checkups. About 3,150 adults aged 65 and older without prior memory loss diagnosis will participate. The goal is to see if these tools lead to earlier and more accurate detection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,281 people

The number who actually took part.

Started

Nov 2023

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 65 years or older * At least one visit to primary care practice within the past year * Ability to provide informed consent * Ability to communicate in English or Spanish * Available EHR data from at least the past three years Exclusion Criteria: * Prior ADRD or mild cognitive impairment diagnosis as determined by ICD-10 code * Evidence of any history of prescription for a cholinesterase inhibitors or memantine. * Has serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code * Permanent resident of a nursing facility

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alzheimer disease and related dementias (ADRD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alzheimer disease and related dementias (ADRD)

Contacts and locations

Locations

  • University of Miami School of Medicine

    Boca Raton, Florida, 33431 -6437, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.